Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.
2.

Cytotoxic, apoptotic, and sensitization properties of ent-kaurane-type diterpenoids from Croton tonkinensis Gagnep on human liver cancer HepG2 and Hep3b cell lines.

Pham MQ, Iscache AL, Pham QL, Gairin JE.

Fundam Clin Pharmacol. 2016 Apr;30(2):137-46. doi: 10.1111/fcp.12176. Epub 2016 Jan 18.

PMID:
26713517
3.

Antiproliferative activity and phenotypic modification induced by selected Peruvian medicinal plants on human hepatocellular carcinoma Hep3B cells.

Carraz M, Lavergne C, Jullian V, Wright M, Gairin JE, Gonzales de la Cruz M, Bourdy G.

J Ethnopharmacol. 2015 May 26;166:185-99. doi: 10.1016/j.jep.2015.02.028. Epub 2015 Feb 19.

PMID:
25701751
4.

Melanoma chemotherapy leads to the selection of ABCB5-expressing cells.

Chartrain M, Riond J, Stennevin A, Vandenberghe I, Gomes B, Lamant L, Meyer N, Gairin JE, Guilbaud N, Annereau JP.

PLoS One. 2012;7(5):e36762. doi: 10.1371/journal.pone.0036762. Epub 2012 May 24.

5.

Concepts and ways to amplify the antitumor immune response.

Rubin B, Gairin JE.

Curr Top Microbiol Immunol. 2011;344:97-128. doi: 10.1007/82_2010_89. Review.

PMID:
20680804
7.

Pharmacological screening of bryophyte extracts that inhibit growth and induce abnormal phenotypes in human HeLa cancer cells.

Krzaczkowski L, Wright M, Rebérioux D, Massiot G, Etiévant C, Gairin JE.

Fundam Clin Pharmacol. 2009 Aug;23(4):473-82. doi: 10.1111/j.1472-8206.2009.00698.x.

PMID:
19709324
8.

Characterization and differential expression of a newly identified phosphorylated isoform of the human 20S proteasome beta7 subunit in tumor vs. normal cell lines.

Eang R, Girbal-Neuhauser E, Xu B, Gairin JE.

Fundam Clin Pharmacol. 2009 Apr;23(2):215-24. doi: 10.1111/j.1472-8206.2009.00665.x.

PMID:
19645816
9.

[Bryophytes, a potent source of drugs for tomorrow's medicine?].

Krzaczkowski L, Wright M, Gairin JE.

Med Sci (Paris). 2008 Nov;24(11):947-53. doi: 10.1051/medsci/20082411947. French.

10.
11.

Inhibition of proteasome activity impairs centrosome-dependent microtubule nucleation and organization.

Didier C, Merdes A, Gairin JE, Jabrane-Ferrat N.

Mol Biol Cell. 2008 Mar;19(3):1220-9. Epub 2007 Dec 19.

12.
13.

Allosteric changes in the TCR/CD3 structure upon interaction with extra- or intra-cellular ligands.

Rubin B, Knibiehler M, Gairin JE.

Scand J Immunol. 2007 Aug-Sep;66(2-3):228-37.

14.

Interactions between CD8alphabeta and the TCRalphabeta/CD3-receptor complex.

Rubin B, Riond J, Leghait J, Gairin JE.

Scand J Immunol. 2006 Sep;64(3):260-70.

15.

The use of mass spectrometry to identify antigens from proteasome processing.

Burlet-Schiltz O, Claverol S, Gairin JE, Monsarrat B.

Methods Enzymol. 2005;405:264-300. Review.

PMID:
16413318
16.

Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation.

Chapiro J, Claverol S, Piette F, Ma W, Stroobant V, Guillaume B, Gairin JE, Morel S, Burlet-Schiltz O, Monsarrat B, Boon T, Van den Eynde BJ.

J Immunol. 2006 Jan 15;176(2):1053-61.

17.

Tinkering with nature: the tale of optimizing peptide based cancer vaccines.

Michielin O, Blanchet JS, Fagerberg T, Valmori D, Rubio-Godoy V, Speiser D, Ayyoub M, Alves P, Luescher I, Gairin JE, Cerottini JC, Romero P.

Cancer Treat Res. 2005;123:267-91. Review. No abstract available.

PMID:
16211875
18.

Effect of ajoene, a natural antitumor small molecule, on human 20S proteasome activity in vitro and in human leukemic HL60 cells.

Xu B, Monsarrat B, Gairin JE, Girbal-Neuhauser E.

Fundam Clin Pharmacol. 2004 Apr;18(2):171-80.

PMID:
15066131
19.

Characterization of protein variants and post-translational modifications: ESI-MSn analyses of intact proteins eluted from polyacrylamide gels.

Claverol S, Burlet-Schiltz O, Gairin JE, Monsarrat B.

Mol Cell Proteomics. 2003 Aug;2(8):483-93. Epub 2003 Jun 27.

20.

T cells infiltrate the brain in murine and human transmissible spongiform encephalopathies.

Lewicki H, Tishon A, Homann D, Mazarguil H, Laval F, Asensio VC, Campbell IL, DeArmond S, Coon B, Teng C, Gairin JE, Oldstone MB.

J Virol. 2003 Mar;77(6):3799-808.

21.

Mapping and structural dissection of human 20 S proteasome using proteomic approaches.

Claverol S, Burlet-Schiltz O, Girbal-Neuhauser E, Gairin JE, Monsarrat B.

Mol Cell Proteomics. 2002 Aug;1(8):567-78.

22.

A new generation of Melan-A/MART-1 peptides that fulfill both increased immunogenicity and high resistance to biodegradation: implication for molecular anti-melanoma immunotherapy.

Blanchet JS, Valmori D, Dufau I, Ayyoub M, Nguyen C, Guillaume P, Monsarrat B, Cerottini JC, Romero P, Gairin JE.

J Immunol. 2001 Nov 15;167(10):5852-61.

23.

Pleiotropic effects of post-translational modifications on the fate of viral glycopeptides as cytotoxic T cell epitopes.

Hudrisier D, Riond J, Mazarguil H, Gairin JE.

J Biol Chem. 2001 Oct 12;276(41):38255-60. Epub 2001 Jul 30.

24.

Common antiviral cytotoxic t-lymphocyte epitope for diverse arenaviruses.

Oldstone MB, Lewicki H, Homann D, Nguyen C, Julien S, Gairin JE.

J Virol. 2001 Jul;75(14):6273-8.

25.
26.

Cutting edge: CTLs rapidly capture membrane fragments from target cells in a TCR signaling-dependent manner.

Hudrisier D, Riond J, Mazarguil H, Gairin JE, Joly E.

J Immunol. 2001 Mar 15;166(6):3645-9.

28.

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells.

Morel S, Lévy F, Burlet-Schiltz O, Brasseur F, Probst-Kepper M, Peitrequin AL, Monsarrat B, Van Velthoven R, Cerottini JC, Boon T, Gairin JE, Van den Eynde BJ.

Immunity. 2000 Jan;12(1):107-17.

30.

Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses.

Pérarnau B, Saron MF, Reina San Martin B, Bervas N, Ong H, Soloski MJ, Smith AG, Ure JM, Gairin JE, Lemonnier FA.

Eur J Immunol. 1999 Apr;29(4):1243-52.

31.
32.

A structure-based approach to designing non-natural peptides that can activate anti-melanoma cytotoxic T cells.

Ayyoub M, Mazarguil H, Monsarrat B, Van den Eynde B, Gairin JE.

J Biol Chem. 1999 Apr 9;274(15):10227-34.

33.

In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.

von Herrath MG, Coon B, Lewicki H, Mazarguil H, Gairin JE, Oldstone MB.

J Immunol. 1998 Nov 1;161(9):5087-96.

35.
37.

Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2.

Manchester M, Gairin JE, Patterson JB, Alvarez J, Liszewski MK, Eto DS, Atkinson JP, Oldstone MB.

Virology. 1997 Jun 23;233(1):174-84.

38.

Pathogenesis and treatment of virus-induced autoimmune diabetes: novel insights gained from the RIP-LCMV transgenic mouse model.

von Herrath MG, Homann D, Gairin JE, Oldstone MB.

Biochem Soc Trans. 1997 May;25(2):630-5. Review. No abstract available.

PMID:
9191170
39.

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.

Borrow P, Lewicki H, Wei X, Horwitz MS, Peffer N, Meyers H, Nelson JA, Gairin JE, Hahn BH, Oldstone MB, Shaw GM.

Nat Med. 1997 Feb;3(2):205-11.

PMID:
9018240
41.

Characterization of an epitope of the human cytomegalovirus protein IE1 recognized by a CD4+ T cell clone.

Gautier N, Chavant E, Prieur E, Monsarrat B, Mazarguil H, Davrinche C, Gairin JE, Davignon JL.

Eur J Immunol. 1996 May;26(5):1110-7.

PMID:
8647175
44.

CTL escape viral variants. I. Generation and molecular characterization.

Lewicki H, Tishon A, Borrow P, Evans CF, Gairin JE, Hahn KM, Jewell DA, Wilson IA, Oldstone MB.

Virology. 1995 Jun 20;210(1):29-40.

46.

Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus.

von Herrath MG, Dockter J, Nerenberg M, Gairin JE, Oldstone MB.

J Exp Med. 1994 Nov 1;180(5):1901-10.

48.

Antigen presentation and cytotoxic T lymphocyte killing studied in individual, living cells.

Hahn K, DeBiasio R, Tishon A, Lewicki H, Gairin JE, LaRocca G, Taylor DL, Oldstone M.

Virology. 1994 Jun;201(2):330-40.

PMID:
8184542

Supplemental Content

Loading ...
Support Center